RxSight (RXST) Asset Writedowns and Impairment (2020 - 2026)
RxSight's (RXST) quarterly Asset Writedowns and Impairment came in at $60000.0 in Q1 2026, up 93.55% YoY from $31000.0 in Q1 2025, and down 90.26% on a QoQ basis from $616000.0 in Q4 2025.
RxSight (RXST) Asset Writedowns and Impairment (2020 - 2026) Analysis & Trends
RxSight (RXST) has 7 years of Asset Writedowns and Impairment data on file, last reported at $60000.0 in Q1 2026.
- Quarterly Asset Writedowns and Impairment rose 93.55% year-over-year to $60000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 million (up 505.25% YoY) and the FY2025 annual result came in at $1.9 million, up 378.22% from the prior year.
- Asset Writedowns and Impairment declined to $60000.0 in Q1 2026, from $616000.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $1.2 million in Q2 2025 to a low of -$1000.0 in Q3 2023.
- A 5-year average of $194823.5 and a median of $71000.0 in 2024 frame the typical range for Asset Writedowns and Impairment.
- Annual changes were most pronounced in 2023 — Asset Writedowns and Impairment sank 100.3% — and 2024, when it surged 16700.0%.
- Tracing RXST's Asset Writedowns and Impairment over 5 years: stood at $298000.0 in 2022, then slumped by 49.33% to $151000.0 in 2023, then slumped by 52.98% to $71000.0 in 2024, then jumped by 767.61% to $616000.0 in 2025, then slumped by 90.26% to $60000.0 in 2026.
- The last three Asset Writedowns and Impairment figures came in at $60000.0 (Q1 2026), $616000.0 (Q4 2025), and $66000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | RxSight | 250.81 Mn | -153.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.12 Mn |
| Jun 30, 2026 | 1.12 Mn |
| Mar 31, 2026 | 60,000.00 |
| Mar 31, 2026 | 60,000.00 |
| Dec 31, 2025 | 616,000.00 |
| Dec 31, 2025 | 616,000.00 |
| Sep 30, 2025 | 66,000.00 |
| Sep 30, 2025 | 66,000.00 |
| Jun 30, 2025 | 1.22 Mn |
| Jun 30, 2025 | 1.22 Mn |
| Mar 31, 2025 | 31,000.00 |
| Mar 31, 2025 | 31,000.00 |
| Dec 31, 2024 | 71,000.00 |
| Dec 31, 2024 | 71,000.00 |
| Sep 30, 2024 | 166,000.00 |
| Sep 30, 2024 | 166,000.00 |
| Jun 30, 2024 | 56,000.00 |
| Jun 30, 2024 | 56,000.00 |
| Mar 31, 2024 | 111,000.00 |
| Mar 31, 2024 | 111,000.00 |